About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Atlanta | 13,006 Studies Near You

Clinical TrialsAtlanta

Clinical Trials in Atlanta

Discover 13,006 clinical trials near Atlanta, Georgia. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1741-1760 of 13,006 trials

TerminatedA Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic DermatitisThis is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis.NCT00475605·Alabaster, Alabama and 312 others

Find Trials by Condition in Atlanta

Breast Cancerin Atlanta Lung Cancerin Atlanta Prostate Cancerin Atlanta Colorectal Cancerin Atlanta Melanomain Atlanta Leukemiain Atlanta Lymphomain Atlanta Pancreatic Cancerin Atlanta Ovarian Cancerin Atlanta Brain Cancerin Atlanta Diabetes

Data from ClinicalTrials.govTerms

CompletedFLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)Results of recent studies using standard long and short acting insulin therapy (Basal - Bolus or BBI) in type 2 diabetes mellitus (T2DM) have not shown benefits to lower risks for…NCT01524705·San Diego, California and 11 others

CompletedGLobal Assessment of Plaque reGression With a PCSK9 antibOdy as Measured by intraVascular UltrasoundThis study will evaluate whether low-density lipoprotein (LDL-C) lowering with evolocumab (AMG 145) results in greater change from baseline in percent atheroma volume (PAV) at…NCT01813422·Huntsville, Alabama and 225 others

CompletedChlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell TransplantThis randomized phase III trial studies chlorhexidine gluconate cleansing to see how well it works compared to control cleansing in preventing central line associated bloodstream…NCT01817075·Duarte, California and 58 others

Enrolling by invitationA Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell ProductThe primary purpose of this study is to monitor potential long-term risks associated with the administration of SynKIR CAR T cell products.NCT06701201·Denver, Colorado and 6 others

CompletedParallel Arm Trial of AD109 and AD504 In Patients With OSAThis is a phase 2 randomized double-blind placebo-controlled parallel-arm dose finding study to compare fixed dose combinations of AD109 and AD504 to atomoxetine or placebo in…NCT05071612·Los Angeles, California and 24 others

RecruitingTreatment of Hemophilia A Patients With FVIII InhibitorsThis is a non-interventional, multicenter, observational, international study in male persons with haemophilia A who have developed inhibitors to any replacement coagulation…NCT04023019·Atlanta, Georgia and 1 other

RecruitingStudy of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell LymphomaThe goal of this clinical study is to learn more about the safety and effectiveness of the study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory…NCT04989803·Gilbert, Arizona and 33 others

Active not recruitingOlpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes TrialThe primary objective of this trial is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease death (CHD death), myocardial…NCT05581303·Birmingham, Alabama and 736 others

CompletedA Study to Determine the Signs and Symptoms That Impact Daily Life of Participants With Irregular Sleep-Wake Rhythm DisorderThe primary purpose of this study is to determine the signs and symptoms of irregular sleep-wake rhythm disorder (ISWRD) that are important to patients and caregivers of patients…NCT04300569·Costa Mesa, California and 5 others

TerminatedPhase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)The purpose of the study is to assess the long-term safety and efficacy of idebenone in patients with Duchenne muscular dystrophy (DMD) who completed the SIDEROS study.NCT03603288·Birmingham, Alabama and 38 others

TerminatedPhase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaThis is a global, multi-center, Phase 3 study that is randomized 1:1, controlled, and open label to evaluate PDS0101 (Versamune + HPVMix) in combination with pembrolizumab vs…NCT06790966·Phoenix, Arizona and 27 others

CompletedComparison of Insulin Detemir With Insulin Glargine in Type 2 DiabetesThis trial is conducted in the United States of America (USA).NCT00106366·Birmingham, Alabama and 77 others

CompletedEvaluation of Efficacy and Safety of VX-548 for Acute Pain After a BunionectomyThe purpose of this study is to evaluate the efficacy and safety of suzetrigine for acute pain after a bunionectomy.NCT05553366·Sheffield, Alabama and 20 others

Active not recruitingAn Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)This Phase II study aims to evaluate efficacy and safety of the combination of JSB462 (also known as luxdegalutamide) at 100 mg and 300 mg once a day (QD) doses + abiraterone…NCT06991556·La Jolla, California and 65 others

TerminatedExtension Study of ABP-671 in Participants With GoutThe primary objectives of this study are to assess the safety, tolerability, and efficacy of ABP-671 in lowering serum uric acid (sUA) in participants with gout who roll over from…NCT06276556·Tempe, Arizona and 53 others

Active not recruitingRamucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung StudyThis phase III trial compares the effect of the combination of ramucirumab and pembrolizumab versus standard of care chemotherapy for the treatment of non-small cell lung cancer…NCT05633602·Birmingham, Alabama and 565 others

CompletedAfrican American Study of Kidney Disease and Hypertension ABPM Pilot Study4\. Methods 4a.NCT00582777·Birmingham, Alabama and 15 others

CompletedStudy to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar…NCT03201757·Little Rock, Arkansas and 84 others

CompletedGLORIA-AF Registry Program - Second and Third PhasesIn this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real…NCT01468701·Mobile, Alabama and 665 others

PreviousPage 88 of 651Next

in Atlanta

Heart Diseasein Atlanta